Status:
COMPLETED
Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma
Lead Sponsor:
Ge Zheng
Conditions:
Lymphoma
Eligibility:
All Genders
Brief Summary
Lymphoma is a highly heterogeneous blood malignancy. It is very important to search for relative specific diagnostic markers that can detect related lymphoma in early stage for the treatment and long-...
Detailed Description
1. Patients with series and matched lymphoma who were refractory to initial diagnosis, remission and recurrence were enrolled, our research group will collected patient information comprehensively and...
Eligibility Criteria
Inclusion
- patients of lymphoma diagnosed of de novo, CR, relapsed/refractory, be willing to receive treatment
Exclusion
- leukemia
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04062877
Start Date
July 1 2018
End Date
December 30 2021
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Hematology Southeast University Department of Hematology Zhongda Hospital Southeast University Medical School
Nanjing, Jiangsu, China, 210000